Some 14 commercial startup companies came out of the University of California Davis in its 2015-2016 fiscal year, matching a record set two years ago.
The companies vary from technology outfits to medically-oriented businesses, and they also run the gamut of fledgling startups to enterprises that have raised millions of dollars in financing.
Last year, 13 companies launched out of the campus. Those companies were based on UC Davis research or were formed following some campus event, such as the Big Bang Business Competition. In the year ended 2014, 14 startups launched from the University.
The most recent fiscal year's companies were:
• A-Chip — Which was developing a diagnostic tool for evaluating a patient’s risk for a repeat heart attack.
• AccenGen Therapeutics — Investigated anti-inflammatories for unmet needs, such as sinusitis, pain, cardiovascular, respiratory indications and cancer.
• Amaryllis Nucleics — Investigated RNA-sequencing library synthesis for diagnostics, pharmaceutical development and food security.
• Biomass Liquefaction Technologies — Which was developing a process for energy-efficient high liquefaction of biomass.
• Foodful.ly — A winner in the UC Davis Graduate School of Management’s 2015 Big Bang Business Competition. It developed an app to reduce food waste. The application reminds people to use the food they’ve already bought and offers recipes for that food.
• GlycoHub — A developer of efficient enzymatic approaches for high-yield and cost-effective production of complex glycans.
• Isometric Imaging Corp. — Developed computer tomography for early detection and diagnosis of breast cancer.
• LOGOS4n — Developed high-resolution genetics, genome and DNA surveillance technologies for precision diagnostics.
• MUSE Microscopy Inc. — Proposes a new way for pathologists to identify disease. Its slide-free microscopy technology was jointly developed with Lawrence Livermore National Laboratory, which is co-managed by the University of California.
• Protein Architects — Developing proteins to be used as molecular building blocks in self-assembly of nanoparticle-based devices and materials.
• Sapience Therapeutics — Developing therapeutics for major unmet medical needs, particularly high-mortality cancers.
• SensIT — Developing micro-electromechanical chemical sensors for information systems.
• VenoSense — Developing a wearable sensor to manage chronic venous disorder.
• Vizzario Inc. — Developing a portable diagnostic for concussions and traumatic brain injury. Vizzario Inc. in December raised $2 million. In April, Rancho Cordova-based eyecare giant VSP Global announced that VSP had made that investment into Vizzario, which is now based in Los Angeles.